Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
This final rule revises the Medicare Advantage (Part C), Medicare Prescription Drug Benefit (Part D), Medicare cost plan, and Programs of All-Inclusive Care for the Elderly (PACE) regulations to implement changes related to prescription drug coverage, the Medicare Prescription Payment Plan, dual eligible special needs plans (D-SNPs), Part C and D Star Ratings, and other programmatic areas, including the Medicare Drug Price Negotiation Program. This final rule also codifies existing sub-regulatory guidance in the Part C and Part D programs.
Published
Apr 15, 2025
Effective
Jun 3, 2025
Citation
90 FR 15792
Agencies
2
Full text not available in our database.
View on Federal Register →Get a plain-English explanation of what this regulation does, which agencies are responsible, and how it affects existing rules.
No document text available yet
CMS-4208-F
0938-AV40
42 CFR 417
42 CFR 422
42 CFR 423
42 CFR 460